Skip to main content

NCCN Guidelines Insights: Multiple Myeloma, Version 1.2020.

Publication ,  Journal Article
Kumar, SK; Callander, NS; Hillengass, J; Liedtke, M; Baljevic, M; Campagnaro, E; Castillo, JJ; Chandler, JC; Cornell, RF; Costello, C; Godby, K ...
Published in: J Natl Compr Canc Netw
October 1, 2019

The NCCN Guidelines for Multiple Myeloma provide recommendations for diagnosis, workup, treatment, follow-up, and supportive care for patients with monoclonal gammopathy of renal significance, solitary plasmacytoma, smoldering myeloma, and multiple myeloma. These NCCN Guidelines Insights highlight some of the important updates and changes in the 1.2020 version of the NCCN Guidelines for Multiple Myeloma.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Natl Compr Canc Netw

DOI

EISSN

1540-1413

Publication Date

October 1, 2019

Volume

17

Issue

10

Start / End Page

1154 / 1165

Location

United States

Related Subject Headings

  • Oncology & Carcinogenesis
  • Multiple Myeloma
  • Humans
  • 4203 Health services and systems
  • 3211 Oncology and carcinogenesis
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Kumar, S. K., Callander, N. S., Hillengass, J., Liedtke, M., Baljevic, M., Campagnaro, E., … Kumar, R. (2019). NCCN Guidelines Insights: Multiple Myeloma, Version 1.2020. J Natl Compr Canc Netw, 17(10), 1154–1165. https://doi.org/10.6004/jnccn.2019.0049
Kumar, Shaji K., Natalie S. Callander, Jens Hillengass, Michaela Liedtke, Muhamed Baljevic, Erica Campagnaro, Jorge J. Castillo, et al. “NCCN Guidelines Insights: Multiple Myeloma, Version 1.2020.J Natl Compr Canc Netw 17, no. 10 (October 1, 2019): 1154–65. https://doi.org/10.6004/jnccn.2019.0049.
Kumar SK, Callander NS, Hillengass J, Liedtke M, Baljevic M, Campagnaro E, et al. NCCN Guidelines Insights: Multiple Myeloma, Version 1.2020. J Natl Compr Canc Netw. 2019 Oct 1;17(10):1154–65.
Kumar, Shaji K., et al. “NCCN Guidelines Insights: Multiple Myeloma, Version 1.2020.J Natl Compr Canc Netw, vol. 17, no. 10, Oct. 2019, pp. 1154–65. Pubmed, doi:10.6004/jnccn.2019.0049.
Kumar SK, Callander NS, Hillengass J, Liedtke M, Baljevic M, Campagnaro E, Castillo JJ, Chandler JC, Cornell RF, Costello C, Efebera Y, Faiman M, Garfall A, Godby K, Holmberg L, Htut M, Huff CA, Kang Y, Landgren O, Malek E, Martin T, Omel J, Raje N, Sborov D, Singhal S, Stockerl-Goldstein K, Tan C, Weber D, Johnson-Chilla A, Keller J, Kumar R. NCCN Guidelines Insights: Multiple Myeloma, Version 1.2020. J Natl Compr Canc Netw. 2019 Oct 1;17(10):1154–1165.

Published In

J Natl Compr Canc Netw

DOI

EISSN

1540-1413

Publication Date

October 1, 2019

Volume

17

Issue

10

Start / End Page

1154 / 1165

Location

United States

Related Subject Headings

  • Oncology & Carcinogenesis
  • Multiple Myeloma
  • Humans
  • 4203 Health services and systems
  • 3211 Oncology and carcinogenesis